A double-blind placebo-controlled study with granulocyte-macrophage colony-stimulating factor during chemotherapy for ovarian carcinoma.

Elisabeth G.E. de Vries, Bonne Biesma, Phb Willemse, +4

PubMed

ImmunologyGynecologyPathologyMetronomic ChemotherapyImmunotherapy +19

Hepatic metabolism of paclitaxel and its impact in patients with altered hepatic function.

Vrn Panday, Huizing Mt, Phb Willemse, +4

PubMed

Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers

Bonne Biesma, Phb Willemse, NH Mulder, +6

British Journal of Cancer

Tumor BiologyTumoral PathologyMalignant DiseaseMedicineImmunology +7

A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 days

Elisabeth G.E. de Vries, Phb Willemse, Henk‐Jan Guchelaar, +3

British Journal of Cancer

Medicinal ChemistryBiochemistryMedicineNatural SciencesPharmacotherapy +2

Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer

G.J. Veldhuis, Henk‐Jan Guchelaar, Phb Willemse, +7

British Journal of Cancer

MedicinePharmacologyPharmacokinetic StudyGynecologyRelapsed Ovarian Cancer +6

Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposide

RS de Jong, NH Mulder, DRA Uges, +6

British Journal of Cancer

Molecular PharmacologyMedicineOral EtoposideClinical PharmacologyPharmacotherapy +4

Prognostic factors in ovarian cancer: current evidence and future prospects

Anne P.G. Crijns, H. Marike Boezen, Jan P. Schouten, +5

European Journal of Cancer Supplements

Tumoral PathologyMedicineGynecologyPathologyOncology +3

Endocrine effects of medroxyprogesterone acetate: relation between plasma levels and suppression of adrenal steroids in patients with breast cancer.

H Vanveelen, Phb Willemse, Dirk Th. Sleijfer, +2

PubMed

Medroxyprogesterone AcetateMedical TreatmentEndocrine-related CancerPlasma LevelsMedicine +13

The value of AFP and HCG half lives in predicting the efficacy of combination chemotherapy in patients with non-seminomatous germ cell tumors of the testis.

Phb Willemse, Dirk Th. Sleijfer, Hs Koops, +5

PubMed

Hematological MalignancyHcg Half LifeCombination ChemotherapyGenitourinary CancerLinear Ahl +13

A cost-utility analysis comparing second-line chemotherapy schemes in patients with metastatic breast cancer

Ningfeng Fiona Li, Michel van Agthoven, Phb Willemse, +1

Anti-Cancer Drugs

Metastatic Breast CancerOncologyCost-utility AnalysisHealth EconomicsBreast Oncology +12